Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 study of tocilizumab (RoActemra/Actemra) in patients with moderate-to-severe rheumatoid arthritis has been completed, with results posted. The sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-11-03